Did you see this? Nearly 1 in 10 Americans have asthma. Here's what causes it.
Vertex Pharmaceuticals forecast annual revenue largely above Wall Street estimates on Monday, banking on robust sales of its ...
Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers ...
In adults with cystic fibrosis, gastrointestinal symptoms initially improve with ETI but most do not consistently improve with longer-term use.
Pancreatic enzyme replacement therapy (Pert) provides the enzymes people affected by pancreatic cancer need to absorb ...
Tauranga boy Riaan Hamilton has cystic fibrosis - the 3-year-old often gets sick, has been hospitalised several times, and is ...
Sionna Therapeutics has closed its initial public offering, raising $191 million for its pipeline of therapies for cystic ...
A study led by TUM researchers finds that cystic fibrosis alters immune cells early in life, likely before birth. These ...
Background Early-life inflammation has long been recognised as a key pathophysiological process in the evolution of cystic ...
Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers from the Technical University of Munich (TUM) have discovered that the ...
DelveInsight's Airway Clearance Devices for Cystic Fibrosis Market Insights report provides the current and forecast market ...
Sionna Therapeutics SION) stock rises as the clinical-stage biopharma focused on cystic fibrosis therapies makes its public ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback